.png){kind=icon}
返回
F
Feng Ju
department of pharmaceutical affairs management
5H指数
20论文数
95被引数
收录论文 5
发表时间
.png){kind=icon}
For Advanced Oesophageal Squamous Cell Carcinoma, PD-1 Antibody Combined with Chemotherapy Improves Progression-Free Survival Compared with Monotherapy or Chemotherapy Alone as First-Line Treatment: A Retrospective Study with Prognostic Biomarker Analysis对于晚期食管鳞状细胞癌，PD-1抗体联合化疗作为一线治疗与单药治疗或单独化疗相比可改善无进展生存期：一项具有预后生物标志物分析的回顾性研究.png)
OAAI
.png){kind=icon}
OAAI.png){kind=icon}
分享.png){kind=icon}
收藏